Northwest Biotherapeutics (NWBO) Reports Q3 Loss of $0.35/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/5/2026

1. PTC
2. NVDA
3. PCVX
4. META
5. MSFT
6. SPY
7. GMAB
8. USO
9. GOOGL
10. AMD

Go back to Northwest Biotherapeutics (NWBO) Reports Q3 Loss of $0.35/Share

Northwest Biotherapeutics (NWBO) Reports $35M in Financing

November 19, 2014 3:38 PM EST

Northwest Biotherapeutics (NASDAQ: NWBO) announced today two financings totaling $35 million. The financings include a $25 million equity investment by UK based C.F. Woodford Equity Income Fund ("Woodford"), and a $10 million mortgage on the Company's recently acquired UK facility.

Woodford purchased $25 million of unregistered shares of the Company's common stock at $5.79 per share, for a total of 4,317,790 shares. The Company agreed to undertake registration of the shares within the next couple of months.

"We are excited to have the UK's leading biotech investor come on board with NW Bio," commented... More